Fermelanta is a Japan-based biotech company that makes beneficial plant-based chemicals by microorganisms. We transform the traditional supply chain depending on agricultural cultivation and extraction into a next-gen microbial fermentation process that can offer low-cost and high-quality products timely. Our cutting-edge technology is introduction and expression techniques and knowhow of unprecedented foreign genes in a cell factory to make microorganisms produce extrinsic metabolites for industrial usage. The target natural molecules are used for health food, cosmetics or approved drugs. Founded in October 2022, we are currently in a lab-based R&D stage and under the first-financing seed round.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 3-570 Suematsu, Nonoichi-City,ishikawa 9218836,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://fermelanta.com/
- Keywords
- Synthetic Biology, Metabolic Engineering, Genetic Engineering, Chemical Engineering, Applied Microbiology, Molecular Biology.
- HQ
- Nonoichi-city, Ishikawa
Fermelanta, Inc. Questions
Fermelanta, Inc.'s website is https://fermelanta.com/
Fermelanta, Inc.'s LinkedIn profile is https://jp.linkedin.com/company/fermelanta
Fermelanta, Inc. has
12 employees.
View email and phone details for 12
employees at Fermelanta, Inc..
Fermelanta, Inc.'s industry is
Biotechnology Research
Fermelanta, Inc.'s top competitors are
Ibody Inc.,
Towing Co., Ltd.,
Sagri Co., Ltd,
Kisui (輝翠),
Jetro Startup,
Ac-Planta Inc.,
Ac-Planta Inc.,
Bakar Bio Labs,
Symbiobe,
Ef Polymer Global.
Fermelanta, Inc.'s categories are Biotechnology Research
Fermelanta, Inc.'s founding year is 2022
